Cell & Gene Therapy CEO
Date: Location: Cost:
September 25, 2017 Four Seasons Boston
200 Boylston Street
Boston, MA 02116
(617) 338-4400
Location >

Starting at $1950


Dress Code:
Business Attire


Cell & Gene Therapy CEO - September 25 - DRAFT

Speakers and Co-Hosts Include: George Church, Professor of Genetics, Harvard Medical School; Olivier Danos,  CSO, Regenxbio; John DawsonCEO, Oxford Biomedica; Adam GridleyPresident & CEO, Histogenics; Sven KiliVP, Gene Therapy Development Head, GlaxoSmithKline; Gregory LaRosaCSO & SVP, Rare Disease Research, Pfizer; Christopher LooseCo-Founder & CSO, Frequency Therapeutics; Geoff MacKayPresident & CEO, AvroBio; James NobleCEO, Adaptimmune; Amber SalzmanPresident & CEO, Adverum; Alvin ShihCEO, Enzyvant;  Sue WasherPresident & CEO, AGTC

Time Agenda
8:00-9:00 am

Registration and Networking Breakfast

9:00-9:15 am

Welcome and Opening Remarks

9:15-9:45 am

2017 Industry Outlook: What's Driving Development in Cell & Gene Therapies?

9:45-10:15 am

Business Model Efficiencies: Identifying and Overcoming Hurdles

10:15-10:35 am

Moderated Keynote

10:35-11:05 am

Networking Break

11:05-11:35 am

Maximizing Tech Transfer for Therapeutic Development

11:35-12:05 pm

Overcoming Technology Challenges in Cell & Gene Therapy Companies

12:05-12:35 pm

Leveraging Ideal Partnerships in Cell & Gene Therapy

12:35-1:35 pm

Networking Lunch

1:35-2:05 pm

Engaging with Regulators: When and How?

2:05-2:35 pm

Streamlining Manufacturing and Delivery Challenges

2:35-3:05 pm

Financing Innovation: Attracting Investment

3:05-3:35 pm

Networking Break

3:35-3:55 pm

Fireside Chat

3:55-4:25 pm

Commercial Optimization: Overcoming Hurdles to Market Access

4:25-4:55 pm

Outlook on 2018: Trends to Watch

4:55-6:00 pm

Cocktail Reception

Supporting Sponsors: (see all sponsors)